Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )

NCT02117791 · clinicaltrials.gov ↗

COMPLETED

Status

1298

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: Riociguat (ADEMPAS, BAY63-2521)

Sponsor

Bayer